← Leaderboards
Joan Marie Bathon
Johns Hopkins University
$16,318,293
Attributed
$21,785,550
Total exposure
15
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.4M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$21,785,550 · 15
By mechanism
R01$10,642,616 · 3
U01$8,651,153 · 1
M01$930,296 · 8
T32$741,678 · 1
U34$719,807 · 1
R55$100,000 · 1
Top collaborators
- Daniel Hal Solomon8 shared
- Robert Winchester5 shared
- Jon T Giles1 shared
- Andreas H Hielscher1 shared
- Ahmed A Tawakol1 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Joao A C Lima$20,316,320
- Gordon Frank Tomaselli$21,784,029
- Joshua M Hare$39,853,111
- Mehran Armand$9,641,501
- Steven Paul Keller$853,200
Others in their field
Top investigators on “Rheumatoid Arthritis”
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$57,671,528
- Lionel B Ivashkiv · Hospital For Special Surgery$38,096,851
- Paul M. Ridker · Brigham And Women'S Hospital$34,275,148
- V Michael Holers · University Of Colorado Denver$28,178,502
- Michael B Brenner · Brigham And Women'S Hospital$26,598,289
- Betty Diamond · Feinstein Institute For Medical Research$20,428,564
Research focus
Rheumatoid ArthritisInflammationCardiovascular DiseasesInflammatoryEventCessation Of LifeAtherosclerosisBiological MarkersImageFundingRisk FactorsMorbidity - Disease RateX-Ray Computed TomographyAffectTnf GeneUptakePhenotypeMethotrexateArthritisFluorodeoxyglucose Positron Emission TomographyImaging ModalityArthritis TherapyPet/Ct ScanDisease Remission
Grant awards (45)
Multidisciplinary Training in Molecular and Translational Rheumatology Research$184,580
T32 · FY2025 · AR · contact PI
Multidisciplinary Training in Molecular and Translational Rheumatology Research$137,882
T32 · FY2024 · AR · contact PI
Neuroimaging Measures of Psychosocial Stress as Predictors of Articular and Arterial Inflammation, Cardiometabolic Disease, and Treatment Response in Rheumatoid Arthritis$505,842
R01 · FY2023 · AR · contact PI
Multidisciplinary Training in Molecular and Translational Rheumatology Research$157,476
T32 · FY2023 · AR · contact PI
Inflammation and Cardiovascular Disease in Rheumatoid Arthritis$675,863
R01 · FY2022 · AR · contact PI
Multidisciplinary Training in Molecular and Translational Rheumatology Research$168,565
T32 · FY2022 · AR · contact PI
Inflammation and Cardiovascular Disease in Rheumatoid Arthritis$705,302
R01 · FY2021 · AR · contact PI
Treatments Against RA and Effect on FDG PET CT: The TARGET TRIAL$566,969
U01 · FY2021 · AR
Adipose Inflammation in Rheumatoid Arthritis$483,599
R01 · FY2021 · AR · contact PI
Multidisciplinary Training in Molecular and Translational Rheumatology Research$93,175
T32 · FY2021 · AR · contact PI
Treatments Against RA and Effect on FDG PET CT: The TARGET TRIAL$1,594,208
U01 · FY2020 · AR
Treatments Against RA and Effect on FDG PET CT:The TARGET Trial$180,878
U01 · FY2020 · AR
Inflammation and Cardiovascular Disease in Rheumatoid Arthritis$538,532
R01 · FY2019 · AR · contact PI
Inflammation and Cardiovascular Disease in Rheumatoid Arthritis$100,000
R01 · FY2019 · AR · contact PI
Inflammation and Cardiovascular Disease in Rheumatoid Arthritis$585,241
R01 · FY2018 · AR · contact PI
Inflammation and Cardiovascular Disease in Rheumatoid Arthritis$159,998
R01 · FY2018 · AR · contact PI
Treatments Against RA and Effect on FDG PET CT: The TARGET TRIAL$2,646,510
U01 · FY2017 · AR
Inflammation and Cardiovascular Disease in Rheumatoid Arthritis$600,153
R01 · FY2017 · AR · contact PI
Inflammation and Cardiovascular Disease in Rheumatoid Arthritis$159,998
R01 · FY2017 · AR · contact PI
Treatments Against RA and Effect on FDG PET CT: The TARGET TRIAL$2,699,027
U01 · FY2016 · AR
Treatments Against RA and Effect on FDG PET CT: The TARGET TRIAL$963,561
U01 · FY2015 · AR
Inflammation and Cardiovascular Disease in RA$557,011
R01 · FY2015 · AR · contact PI
Inflammation and Cardiovascular Disease in RA$644,996
R01 · FY2014 · AR · contact PI
Treat to Target to Reduce Atherosclerosis in Rheumatoid Arthritis$350,488
U34 · FY2014 · AR
Inflammation and Cardiovascular Disease in RA$687,197
R01 · FY2013 · AR · contact PI
Treat to Target to Reduce Atherosclerosis in Rheumatoid Arthritis$369,319
U34 · FY2013 · AR
Inflammation and cardiovascular disease in RA$147,421
R01 · FY2013 · AR · contact PI
Inflammation and Cardiovascular Disease in RA$584,392
R01 · FY2012 · AR · contact PI
Inflammation and Cardiovascular Disease in RA$50,000
R01 · FY2012 · AR · contact PI
Inflammation and Cardiovascular Disease in RA$603,165
R01 · FY2010 · AR · contact PI
Inflammation and Cardiovascular Disease in RA$495,853
R01 · FY2008 · AR · contact PI
Inflammation and Cardiovascular Disease in RA$571,357
R01 · FY2007 · AR · contact PI
OSTEOARTHRITIS INITIATIVE: A KNEE STUDY$58,917
M01 · FY2007 · RR · contact PI
ESCAPE - RA TRIAL$4,516
M01 · FY2007 · RR · contact PI
Inflammation and Cardiovascular Disease in RA$621,458
R01 · FY2006 · AR · contact PI
OSTEOARTHRITIS INITIATIVE: A KNEE STUDY$565,096
M01 · FY2006 · RR · contact PI
ESCAPE - RA TRIAL$86,757
M01 · FY2006 · RR · contact PI
SUPPRESSION OF THE GROWTH HORMONE/INSULIN-LIKE GROWTH FACTOR-1 (GH/IGF-1) AXI$1,759
M01 · FY2006 · RR · contact PI
Inflammation and Cardiovascular Disease in RA$616,356
R01 · FY2005 · AR
OSTEOARTHRITIS INITIATIVE: A KNEE STUDY$189,229
M01 · FY2005 · RR
ESCAPE - RA TRAIL$15,169
M01 · FY2005 · RR
SUPPRESSION OF THE GROWTH HORMONE/INSULIN-LIKE GROWTH FACTOR-1 (GH/IGF-1) AXIS$6,388
M01 · FY2005 · RR
Inflammation and Cardiovascular Disease in RA$548,882
R01 · FY2004 · AR
Suppression of the Growth Hormone/Insulin-Like Growth Factor-1 (GH/IGF-1) Axi...$2,465
M01 · FY2004 · RR
Inflammation and Cardiovascular Disease in RA$100,000
R55 · FY2003 · AR